2022

Arboretum Home Page

Midwest Growth Capital Symposium to Feature Crosslink Capital and Arboretum Ventures Keynotes for 2022

Organizers of the Midwest Growth Capital Symposium (MGCS) announced today that Michael Stark, Jan Garfinkle, and Tim Petersen will Keynote the…

Arboretum_JDApril 8, 2022

Fifth Eye News Page

AirStrip® Adds Analytics Capabilities to Virtual Acute Care Platform via Partnership with Fifth Eye™

Fifth Eye™, a provider of intuitive real-time clinical analytics, announced today that it has entered…

Arboretum_JDApril 5, 2022

EQRx News Page

EQRx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Progress

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative…

Arboretum_JDMarch 23, 2022

Home Page News Page Strata Oncology

Strata Oncology Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022

Strata Oncology, a precision oncology company advancing new molecular indications for cancer therapies, has been named…

Arboretum_JDMarch 9, 2022

JUMPCODE Genomics News Page

Element Biosciences and Jumpcode Genomics Partner to Validate Jumpcode’s CRISPRclean® Technology

Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a…

Casey FrushourFebruary 28, 2022

Health Scholars News Page

Health Scholars has launched Pediatric Emergency Care™

Pediatric Emergency Care™ will deliver paramedics the immersive practice needed to manage pediatric emergencies in…

Casey FrushourFebruary 3, 2022

Koya Medical News Page

Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…

Casey FrushourFebruary 3, 2022

Fifth Eye News Page Press Release

Fifth Eye Receives FDA Clearance to Market AHI System™

Fifth Eye™, a provider of intuitive real-time clinical analytics, today announced the FDA provided clearance…

Casey FrushourJanuary 31, 2022

EQRx News Page

EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results

EQRx, Inc. (Nasdaq: EQRX) a new type of pharmaceutical company committed to developing and delivering…

Casey FrushourJanuary 18, 2022

EQRx News Page

EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering…

Casey FrushourJanuary 10, 2022

Midwest Growth Capital Symposium to Feature Crosslink Capital and Arboretum Ventures Keynotes for 2022

AirStrip® Adds Analytics Capabilities to Virtual Acute Care Platform via Partnership with Fifth Eye™

EQRx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Progress

Strata Oncology Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022

Element Biosciences and Jumpcode Genomics Partner to Validate Jumpcode’s CRISPRclean® Technology

Health Scholars has launched Pediatric Emergency Care™

Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies

Fifth Eye Receives FDA Clearance to Market AHI System™

EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results

EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines

News & Insights

ARCHIVES